CSA Medical completes enrolment in chronic bronchitis trial

CSA Medical has completed enrolment in its SPRAY-CB trial (NCT03893370) for patients with chronic obstructive pulmonary disease (COPD) with chronic bronchitis (CB). The double-blind, sham-controlled...

Vectorious Medical reports positive data from study of miniature heart sensor

Vectorious Medical Technologies today announced data supporting its V-LAP system and novel therapeutic approach for heart failure. Tel Aviv, Israel–based Vectorious develops a miniature digital...

Genetesis enrols first subject for MICRO2 trial

Genetesis has enrolled the first patient marking the start of its magnetocardiography as a non-invasive diagnostic strategy for suspected myocardial ischemia with the absence...

Spectral AI expands clinical trial sites for pivotal U.S. burn study

Spectral AI, Inc., an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, announced that...

Study shows superiority of Delphinus’s ultrasound tomography system

Delphinus Medical Technologies, a pioneering medical imaging company that developed the SoftVue™ Breast Ultrasound Tomography (UST), announced today the publication of a study comparing...

Sovato completes series of remote robotic surgical tests

Sovato announced it completed a series of remote robotic-assisted surgical procedures using its Sovato remote surgery software platform. Seven surgeons across four specialties performed...

Noah Medical showcases success of Galaxy surgical robotic system 

US-based Noah Medical has published positive data from a clinical study demonstrating the success and safety of its Galaxy surgical robotic system. The results were...

NXTSTIM’s wearable nerve stimulation device helps manage long-term pain

NXTSTIM has announced 18-month data from a real-world study showing that its wearable transcutaneous electrical nerve and electromyographic stimulation device, EcoAI, can help relieve...

Neurolief has positive results in trial of neuromod for depression

Neurolief announced positive results from a clinical trial evaluating its neuromodulation for treatment-resistant depression (TRD). The non-invasive technology, designed for clinic and at-home treatment,...

Latest articles